Advocacy Posts
Explained: the PMPRB’s impact on access to CF medicines and what you can do to help
The Patented Medicine Prices Review Board (PMPRB) and its proposed draft guidelines have become a major concern in the Canadian cystic fibrosis (CF) community. This…
Read More
Advocacy Update & Latest News from Cystic Fibrosis Canada: July 10
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Cystic Fibrosis Canada’s Position on the…
Read More
Advocacy Update & Latest News from CF Canada: June 26
As more provinces are beginning to reopen as a part of the COVID-19 provincial reintegration plans, we hope that you are staying safe and well….
Read More
From the Desk of the CEO
It has been an eventful few weeks and we are seeing positive momentum in our fight for access to cystic fibrosis (CF) medications thanks to…
Read More
pCPA Negotiations for CF Modulators: What Does this Mean for Access?
The pCPA has agreed to begin negotiations with Vertex Pharmaceuticals? What does that mean? This means the public drug plans – those provided by the…
Read More
Advocacy Update & Latest News from CF Canada: May 29
It’s the last week of CF Awareness Month! We hope you are staying safe and well. Here’s a round-up of the latest advocacy updates and…
Read More
Advocacy Update & Latest News from CF Canada: May 22
Please see below for advocacy updates and the latest news from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Constituency Member of Parliament Meeting Challenge…
Read More
Advocacy Update & Latest News from CF Canada: May 15
With Cystic Fibrosis Awareness Month in full swing, we’re pleased to share the latest advocacy updates and recent news from Cystic Fibrosis Canada: #CFCantWait: ADVOCACY…
Read More#CFcantwait Advocacy Update from CF Canada: April 30
Improving access to life-changing cystic fibrosis medications is an important priority for Cystic Fibrosis Canada. Here are the latest updates about it from our leadership…
Read More